share_log

Ginkgo Bioworks: Ginkgo Bioworks Holdings, Inc. - Reverse Split Option Symbol: DNA New Symbol: DNA1

Ginkgo Bioworks: Ginkgo Bioworks Holdings, Inc. - Reverse Split Option Symbol: DNA New Symbol: DNA1

Ginkgo Bioworks：銀杏生物工程控股公司 - 反向拆股選擇
標的代碼: DNA 新代碼: DNA1
OCC期權清算公司 ·  08/19 11:59
Moomoo AI 已提取核心訊息
Ginkgo Bioworks Holdings, Inc., known by its stock symbol DNA, has announced a reverse stock split that will take effect on August 20, 2024. The reverse split will be conducted at a ratio of 1-for-40, resulting in a change of the company's option symbol from DNA to DNA1. Following the split, the new multiplier for options will be set at 100, and the new deliverable per contract will include 2 new Class A Common Shares of Ginkgo Bioworks and cash in lieu of 0.5 fractional shares. The cash portion of the deliverable will be settled once the cash in lieu amount is determined, with the DNA component settling through the National Securities Clearing Corporation (NSCC). The Options Clearing Corporation (OCC) will oversee the settlement of the cash portion and the adjustment of options and futures as per their by-laws.
Ginkgo Bioworks Holdings, Inc., known by its stock symbol DNA, has announced a reverse stock split that will take effect on August 20, 2024. The reverse split will be conducted at a ratio of 1-for-40, resulting in a change of the company's option symbol from DNA to DNA1. Following the split, the new multiplier for options will be set at 100, and the new deliverable per contract will include 2 new Class A Common Shares of Ginkgo Bioworks and cash in lieu of 0.5 fractional shares. The cash portion of the deliverable will be settled once the cash in lieu amount is determined, with the DNA component settling through the National Securities Clearing Corporation (NSCC). The Options Clearing Corporation (OCC) will oversee the settlement of the cash portion and the adjustment of options and futures as per their by-laws.
Ginkgo Bioworks Holdings公司，股票代碼爲DNA，宣佈將於2024年8月20日實施股票拆分。用戶將以1比40的比例進行拆分，導致該公司的期權代碼從DNA更改爲DNA1。在拆分後，期權的新乘數將設置爲100，並且每個合同的新可交付物將包括2個新的Ginkgo Bioworks A類普通股和等價於0.5碎股的現金補償。交付物的現金部分將在確定了現金補償金額後結算，DNA部分將通過國家證券清算公司（NSCC）結算。期權清算公司（OCC）將根據其章程監督現金部分的結算和期貨和期權的調整。
Ginkgo Bioworks Holdings公司，股票代碼爲DNA，宣佈將於2024年8月20日實施股票拆分。用戶將以1比40的比例進行拆分，導致該公司的期權代碼從DNA更改爲DNA1。在拆分後，期權的新乘數將設置爲100，並且每個合同的新可交付物將包括2個新的Ginkgo Bioworks A類普通股和等價於0.5碎股的現金補償。交付物的現金部分將在確定了現金補償金額後結算，DNA部分將通過國家證券清算公司（NSCC）結算。期權清算公司（OCC）將根據其章程監督現金部分的結算和期貨和期權的調整。
有用
沒用

該公告為獨立文件：

獨立文件1

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息